204 results
Page 3 of 11
6-K
EX-99.1
hbrkassi
5 Apr 22
Current report (foreign)
4:07pm
6-K
EX-99.1
zm3gb9alda95
1 Mar 22
BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference
7:00am
40-F
EX-99.1
h1nba700eb65ptk
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.2
s037id0u0ki31h2yc89
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.3
6i3msmg 7m
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.1
l6657
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
6-K
EX-99.1
r2ebi9k
17 Dec 21
BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States
4:03pm
6-K
EX-99.1
yvo9m4g4w7cr2znevigc
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
SUPPL
fw5koj32
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
adt4p4y
14 Dec 21
Registration of securities (Canada)
9:43am
SUPPL
ifkz4y3
13 Dec 21
Supplemental materials (foreign)
5:00pm
6-K
EX-99.1
1wfcquh
13 Dec 21
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:07pm
6-K
EX-99.2
cknjfowj4lgvcxb
13 Dec 21
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:07pm
6-K
EX-99.2
700mxtf7
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
EX-99.1
4s4pog
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
5tbzcu 2u881
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
EX-99.1
teng1ro6ipsdr o0
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
ol8mb206lc3zugff0
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.1
oow3 0l5mcmrbez
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
EX-99.2
v92di l5e
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm